Product Name |
Deschloroethyl bendamustine |
Alternate Names |
Bendamustine Impurities, Impurities of Bendamustine |
CAT No. |
CS-ZH-14778
|
CAS No. |
1219709-86-0 |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
295.76 g/mol |
Mol. For. |
C₁₄H₁₈ClN₃O₂
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Bendamustine |
Canonical Smiles |
CN1C2=C(C=C(C=C2)NCCCl)N=C1CCCC(=O)O |
InchIKey |
UMRNCYQXTUODGC-UHFFFAOYSA-N |
Inchl |
InChI=1S/C14H18ClN3O2/c1-18-12-6-5-10(16-8-7-15)9-11(12)17-13(18)3-2-4-14(19)20/h5-6,9,16H,2-4,7-8H2,1H3,(H,19,20) |
IUPAC |
4-[5-(2-chloroethylamino)-1-methylbenzimidazol-2-yl]butanoic acid |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Deschloroethyl bendamustine is a synthetic compound that is derived from the parent compound bendamustine, which is a chemotherapy drug used to treat various types of cancer. Deschloroethyl bendamustine is a derivative of bendamustine that has been chemically modified to enhance its efficacy and reduce its toxicity.
Deschloroethyl bendamustine works by inhibiting the growth and spread of cancer cells in the body. It is used to treat a variety of cancers, including non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and multiple myeloma. It is also used in combination with other chemotherapy drugs to treat certain types of breast cancer.
Chemically, deschloroethyl bendamustine is a nitrogen mustard alkylating agent that forms cross-links between DNA strands, which ultimately leads to apoptosis, or cell death. Its chemical structure is similar to that of other nitrogen mustard agents, such as cyclophosphamide and melphalan.
Deschloroethyl bendamustine is typically administered intravenously and is generally well-tolerated. However, it can cause side effects such as nausea, vomiting, diarrhea, fatigue, and an increased risk of infection. In rare cases, it can cause more serious side effects, such as anemia, bone marrow suppression, and liver toxicity.
In conclusion, deschloroethyl bendamustine is a chemotherapy drug that is used to treat various types of cancer. Its chemical structure is similar to other nitrogen mustard agents, and it works by inhibiting the growth and spread of cancer cells. While it is generally well-tolerated, it can cause side effects and should only be used under the guidance of a healthcare professional.